These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37226774)

  • 1. Tenecteplase in Acute Stroke: What About the Children?
    Sun LR; Wilson JL; Waak M; Kiskaddon A; Goldenberg NA; Jordan LC; Barry M
    Stroke; 2023 Jul; 54(7):1950-1953. PubMed ID: 37226774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving Thrombolytics: from Alteplase to Tenecteplase.
    Miller SE; Warach SJ
    Neurotherapeutics; 2023 Apr; 20(3):664-678. PubMed ID: 37273127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenecteplase use in the management of acute ischemic stroke: Literature review and clinical considerations.
    Hailu K; Cannon C; Hayes S
    Am J Health Syst Pharm; 2022 Jun; 79(12):944-949. PubMed ID: 35020806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A practice game changer: Impact of tenecteplase for acute ischemic stroke in a multicenter quality improvement project.
    Noh L; Pham F; Haddad L; Burkhard T; Paletz L; Pech M; Lewis M; Manoukian V; Schlick KH; Song S
    Am J Health Syst Pharm; 2022 Apr; 79(9):e149-e153. PubMed ID: 35037028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials.
    Coutts SB; Berge E; Campbell BC; Muir KW; Parsons MW
    Int J Stroke; 2018 Dec; 13(9):885-892. PubMed ID: 30035698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial.
    Kvistad CE; Næss H; Helleberg BH; Idicula T; Hagberg G; Nordby LM; Jenssen KN; Tobro H; Rörholt DM; Kaur K; Eltoft A; Evensen K; Haasz J; Singaravel G; Fromm A; Thomassen L
    Lancet Neurol; 2022 Jun; 21(6):511-519. PubMed ID: 35525250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke: Meta-Analysis of 5 Randomized Trials.
    Burgos AM; Saver JL
    Stroke; 2019 Aug; 50(8):2156-2162. PubMed ID: 31318627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenecteplase to Replace Alteplase? Comparing Thrombolytic Therapies for Acute Ischemic Stroke: June 2023 Annals of Emergency Medicine Journal Club.
    Hanna E; Barrett TW
    Ann Emerg Med; 2023 Jun; 81(6):759-760. PubMed ID: 37210165
    [No Abstract]   [Full Text] [Related]  

  • 9. Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials.
    Xu N; Chen Z; Zhao C; Xue T; Wu X; Sun X; Wang Z
    Drug Des Devel Ther; 2018; 12():2071-2084. PubMed ID: 30013325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation and Fibrinolytic Activity of Tenecteplase and Alteplase in Acute Ischemic Stroke.
    Huang X; Moreton FC; Kalladka D; Cheripelli BK; MacIsaac R; Tait RC; Muir KW
    Stroke; 2015 Dec; 46(12):3543-6. PubMed ID: 26514192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Outcomes of Tenecteplase in Moderate and Severe Ischemic Stroke.
    Kvistad CE; Novotny V; Kurz MW; Rønning OM; Thommessen B; Carlsson M; Waje-Andreassen U; Næss H; Thomassen L; Logallo N
    Stroke; 2019 May; 50(5):1279-1281. PubMed ID: 31009339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenecteplase utility in acute ischemic stroke patients: A clinical review of current evidence.
    Nelson A; Kelly G; Byyny R; Dionne C; Preslaski C; Kaucher K
    Am J Emerg Med; 2019 Feb; 37(2):344-348. PubMed ID: 30471930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenecteplase versus alteplase after acute ischemic stroke at high age.
    Thommessen B; Næss H; Logallo N; Kvistad CE; Waje-Andreassen U; Ihle-Hansen H; Ihle-Hansen H; Thomassen L; Morten Rønning O
    Int J Stroke; 2021 Apr; 16(3):295-299. PubMed ID: 32631157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.
    Huang X; Cheripelli BK; Lloyd SM; Kalladka D; Moreton FC; Siddiqui A; Ford I; Muir KW
    Lancet Neurol; 2015 Apr; 14(4):368-76. PubMed ID: 25726502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial.
    Wang Y; Li S; Pan Y; Li H; Parsons MW; Campbell BCV; Schwamm LH; Fisher M; Che F; Dai H; Li D; Li R; Wang J; Wang Y; Zhao X; Li Z; Zheng H; Xiong Y; Meng X;
    Lancet; 2023 Feb; 401(10377):645-654. PubMed ID: 36774935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion From Intravenous Alteplase to Tenecteplase for Treatment of Acute Ischemic Stroke Across a Large Community Hospital Health System.
    Dittmar E; Wolfel T; Menendez L; Pozo J; Ramirez M; Belnap SC; De Los Rios La Rosa F
    Ann Pharmacother; 2023 Oct; 57(10):1147-1153. PubMed ID: 36688289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenecteplase Versus Alteplase for Acute Stroke: Mortality and Bleeding Complications.
    Murphy LR; Hill TP; Paul K; Talbott M; Golovko G; Shaltoni H; Jehle D
    Ann Emerg Med; 2023 Dec; 82(6):720-728. PubMed ID: 37178103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The promise of tenecteplase in acute stroke: Within reach or beyond approval?
    Zachrison KS; Schwamm LH
    Med; 2022 Oct; 3(10):651-655. PubMed ID: 36202099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
    Logallo N; Novotny V; Assmus J; Kvistad CE; Alteheld L; Rønning OM; Thommessen B; Amthor KF; Ihle-Hansen H; Kurz M; Tobro H; Kaur K; Stankiewicz M; Carlsson M; Morsund Å; Idicula T; Aamodt AH; Lund C; Næss H; Waje-Andreassen U; Thomassen L
    Lancet Neurol; 2017 Oct; 16(10):781-788. PubMed ID: 28780236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenecteplase: More Evidence It Should Replace Alteplase for Ischemic Stroke Treatment.
    Kreitzer N
    Ann Emerg Med; 2023 Dec; 82(6):729-731. PubMed ID: 37598332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.